MedPath

NEO PAUSE INJECTION

NEO PAUSE INJECTION

Discontinued
DIN Number

00147567

Drug Class

Human

Market Date

Dec 31, 1970

Company
HC

neolab inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00147567
AIG Number0206404003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03EA02 TESTOSTERONE AND ESTROGEN
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification68:16.04
Health Canada Classification

ACTIVE INGREDIENTS (2)

ESTRADIOL VALERATEActive
Strength: 6.5 MG / ML
Monograph: ESTRADIOL VALERATE
TESTOSTERONE ENANTHATEActive
Strength: 100 MG / ML
Monograph: TESTOSTERONE ENANTHATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.